semaglutide compounding pharmacy ban FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Semaglutide Sublingual 1mg/ml | NextGenRx

National Association of Boards of Pharmacy (NABP) has documented this pattern internationally, including websites that mimic legitimate sellers, mislabelling products as peptides for research purposes only, and non-delivery scams in which customers pay but receive nothing. None of these routes goes through the MHRA

The science is promising enough to study closely, but practical decisions should wait for stronger evidence, regulatory decisions, and individualized medical guidance

doi: 10.1007/s12035-017-0550-2 107 Diz-ChavesYMastoorZSpuchCGonzlez-MatasLCMalloF

Motion and nausea: Post-injection nausea combined with motion sickness from flights, car journeys, or boat trips can be significantly worse than either alone

But more than anything, she just wanted to see what would happen

[1] [2] The weight reduction and improved insulin sensitivity contribute to favorable changes across multiple cardiometabolic risk factors